# Validation of Blood Biomarkers for Alzheimer's Disease

> **NCT05427448** · NA · COMPLETED · sponsor: **University Hospital, Montpellier** · enrollment: 342 (actual)

## Conditions studied

- Alzheimer Disease
- Mild Cognitive Impairment
- Dementia
- Tauopathies

## Interventions

- **DIAGNOSTIC_TEST:** Measurement of amyloid and pTau blood biomarkers

## Key facts

- **NCT ID:** NCT05427448
- **Lead sponsor:** University Hospital, Montpellier
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-11-24
- **Primary completion:** 2025-05-20
- **Final completion:** 2025-05-20
- **Target enrollment:** 342 (ACTUAL)
- **Last updated:** 2025-12-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05427448

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05427448, "Validation of Blood Biomarkers for Alzheimer's Disease". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05427448. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*